Molecular, Cellular, & Tissue Engineering
Cellulases are of considerable current interest for converting the cellulosic content of biomass to fermentable sugars for biofuels production.
For the past two decades the capability of protein engineers to devise clever tumor-targeting molecules has outstripped our understanding of how these agents distribute through the body and permeate through tumors.
Stem cells have become a promising cell source in the tissue engineering field.
Worth over $30 billion, therapeutic proteins, produced by recombinant mammalian cells, have been the fastest growing class of medicines in industrialized nations.